David Schenkein - Director at Agios Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
AGIO on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

David Schenkein - trading volume in the past year for Agios Pharmaceuticals, Inc.

Holdings reported by David Schenkein for Agios Pharmaceuticals, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common stock 126,242 $6.17 M $48.84 Jun 13, 2024 Direct
Common stock 79,082 $3.86 M $48.84 Jun 13, 2024 Indirect
Restricted stock units 2,120 $104 K $48.84 Jun 20, 2024 Direct Common stock
Stock options (right to buy) 11,774 Jun 20, 2024 Direct Common stock

Transactions reported by David Schenkein for Agios Pharmaceuticals, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership